Can you provide the last earnings date for ENSYSCE BIOSCIENCES INC?
ENSYSCE BIOSCIENCES INC (ENSC) last reported earnings on 3/30/2026.
ENSYSCE BIOSCIENCES INC (ENSC) Earnings History & Surprises
NASDAQ:ENSC • US2936025046
Current stock price
0.38 USD
+0.01 (+2.26%)
Last:
ENSC Earnings overview
Past quarterly earnings results for ENSYSCE BIOSCIENCES INC (ENSC), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.74
- Revenue Estimate
- 1.938M
Last Reported
Most Recent- Release Date
- Mar 30, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.75
- EPS Surprise
- 41.64%
- Revenue Surprise
- 269.02%
Beat Rate
Last 8 Quarters 38%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.75 | -1.29 | 41.64% | 74.14% | 1.882M | 510K | 269.02% | 44.33% |
| Q3 2025 | -1.29 | -0.88 | -46.21% | -222.86% | 493K | 714K | -30.95% | -85.58% |
| Q2 2025 | -0.79 | -1.20 | 34.36% | 76.06% | 1.371M | 663K | 106.79% | 654.13% |
| Q1 2025 | -1.39 | -3.08 | 54.80% | 83.15% | 1.32M | - | 331.69% | |
| Q4 2024 | -2.90 | -2.79 | -3.95% | 85.89% | 1.304M | 255K | 411.37% | 153.19% |
| Q3 2024 | 1.05 | -4.51 | 123.26% | 108.05% | 3.419M | 255K | 1,240.78% | 685.29% |
| Q2 2024 | -3.30 | -5.97 | 44.70% | 77.55% | 181.8K | 306K | -40.59% | -62.90% |
| Q1 2024 | -8.25 | -13.77 | 40.09% | 73.56% | 305.72K | 408K | -25.07% | -61.30% |
| Q4 2023 | -20.55 | -13.31 | -54.38% | 92.49% | 515.03K | 402.9K | 27.83% | -63.98% |
| Q3 2023 | -13.05 | -16.17 | 19.28% | 90.20% | 435.38K | 605.197K | -28.06% | 55.49% |
| Q2 2023 | -14.70 | -41.72 | 64.76% | 98.30% | 490K | 843.203K | -41.89% | 133.33% |
| Q1 2023 | -31.20 | -77.67 | 59.83% | 85.56% | 790K | 969K | -18.47% | 31.67% |
| Q4 2022 | -273.60 | -441.86 | 38.08% | 83.11% | 1.43M | 1.571M | -8.98% | -12.80% |
| Q3 2022 | -133.20 | -587.52 | 77.33% | -18,660.56% | 280K | 1.02M | -72.55% | -76.67% |
| Q2 2022 | -864.00 | -624.24 | -38.41% | - | 210K | 1.02M | -79.41% | -52.27% |
| Q1 2022 | -216.00 | -587.52 | 63.24% | - | 600K | 1.224M | -50.98% | 140.00% |
| Q4 2021 | -1,620.00 | -73.44 | -2,105.88% | - | 1.64M | 1.02M | 60.78% | - |
| Q3 2021 | -0.71 | - | - | 1.2M | - | - | ||
| Q2 2021 | - | - | 440K | - | - | |||
| Q1 2021 | - | - | 250K | - | - | |||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
21.15%
Max EPS beat (4)
54.80%
Min EPS beat (4)
-46.21%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, ENSC has beaten EPS estimates in 3 out of 4 releases
In the last 4 quarters, ENSC has beaten the EPS estimates by 21.1% on average.
Related analysis
ENSYSCE BIOSCIENCES INC / ENSC Earnings FAQ
Did ENSC stock beat earnings estimates in the most recent quarter?
ENSYSCE BIOSCIENCES INC (ENSC) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does ENSC stock beat earnings estimates?
In the last 4 quarters, ENSYSCE BIOSCIENCES INC (ENSC) has beaten EPS estimates in 3 out of 4 releases.